Logo image of CX

CEMEX SAB-SPONS ADR PART CER (CX) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:CX - US1512908898 - ADR

11.66 USD
+0.1 (+0.87%)
Last: 12/19/2025, 8:04:00 PM
11.53 USD
-0.13 (-1.11%)
After Hours: 12/19/2025, 8:04:00 PM
Fundamental Rating

4

Overall CX gets a fundamental rating of 4 out of 10. We evaluated CX against 13 industry peers in the Construction Materials industry. While CX is still in line with the averages on profitability rating, there are concerns on its financial health. CX is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CX had positive earnings in the past year.
CX had a positive operating cash flow in the past year.
Of the past 5 years CX 4 years were profitable.
CX had a positive operating cash flow in each of the past 5 years.
CX Yearly Net Income VS EBIT VS OCF VS FCFCX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

1.2 Ratios

The Return On Assets of CX (4.70%) is worse than 61.54% of its industry peers.
CX's Return On Equity of 10.03% is in line compared to the rest of the industry. CX outperforms 46.15% of its industry peers.
Looking at the Return On Invested Capital, with a value of 5.31%, CX is doing worse than 69.23% of the companies in the same industry.
CX had an Average Return On Invested Capital over the past 3 years of 6.81%. This is below the industry average of 9.37%.
Industry RankSector Rank
ROA 4.7%
ROE 10.03%
ROIC 5.31%
ROA(3y)2.44%
ROA(5y)0.96%
ROE(3y)5.81%
ROE(5y)1.39%
ROIC(3y)6.81%
ROIC(5y)6.3%
CX Yearly ROA, ROE, ROICCX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10 -15

1.3 Margins

CX has a worse Profit Margin (8.62%) than 69.23% of its industry peers.
CX's Profit Margin has improved in the last couple of years.
CX's Operating Margin of 9.55% is on the low side compared to the rest of the industry. CX is outperformed by 76.92% of its industry peers.
CX's Operating Margin has improved in the last couple of years.
The Gross Margin of CX (32.75%) is better than 69.23% of its industry peers.
In the last couple of years the Gross Margin of CX has remained more or less at the same level.
Industry RankSector Rank
OM 9.55%
PM (TTM) 8.62%
GM 32.75%
OM growth 3Y-1.91%
OM growth 5Y2.21%
PM growth 3Y3.44%
PM growth 5Y39.71%
GM growth 3Y1.36%
GM growth 5Y0.48%
CX Yearly Profit, Operating, Gross MarginsCX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CX is destroying value.
CX has a better debt/assets ratio than last year.
CX Yearly Shares OutstandingCX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B
CX Yearly Total Debt VS Total AssetsCX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

CX has an Altman-Z score of 1.66. This is a bad value and indicates that CX is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.66, CX is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
CX has a debt to FCF ratio of 12.73. This is a negative value and a sign of low solvency as CX would need 12.73 years to pay back of all of its debts.
With a Debt to FCF ratio value of 12.73, CX perfoms like the industry average, outperforming 46.15% of the companies in the same industry.
A Debt/Equity ratio of 0.44 indicates that CX is not too dependend on debt financing.
CX has a better Debt to Equity ratio (0.44) than 69.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 12.73
Altman-Z 1.66
ROIC/WACC0.37
WACC14.53%
CX Yearly LT Debt VS Equity VS FCFCX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 0.91 indicates that CX may have some problems paying its short term obligations.
CX has a worse Current ratio (0.91) than 76.92% of its industry peers.
CX has a Quick Ratio of 0.91. This is a bad value and indicates that CX is not financially healthy enough and could expect problems in meeting its short term obligations.
CX's Quick ratio of 0.67 is on the low side compared to the rest of the industry. CX is outperformed by 76.92% of its industry peers.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.67
CX Yearly Current Assets VS Current LiabilitesCX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

3

3. Growth

3.1 Past

CX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -77.22%.
The Earnings Per Share has been growing by 76.58% on average over the past years. This is a very strong growth
The Revenue for CX has decreased by -23.51% in the past year. This is quite bad
Measured over the past years, CX shows a small growth in Revenue. The Revenue has been growing by 4.29% on average per year.
EPS 1Y (TTM)-77.22%
EPS 3Y-35.5%
EPS 5Y76.58%
EPS Q2Q%80%
Revenue 1Y (TTM)-23.51%
Revenue growth 3Y4.05%
Revenue growth 5Y4.29%
Sales Q2Q%3.81%

3.2 Future

The Earnings Per Share is expected to decrease by -18.89% on average over the next years. This is quite bad
Based on estimates for the next years, CX will show a small growth in Revenue. The Revenue will grow by 4.14% on average per year.
EPS Next Y-37.74%
EPS Next 2Y-30.7%
EPS Next 3Y-18.89%
EPS Next 5YN/A
Revenue Next Year-5.27%
Revenue Next 2Y-0.21%
Revenue Next 3Y1.3%
Revenue Next 5Y4.14%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CX Yearly Revenue VS EstimatesCX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5B 10B 15B 20B
CX Yearly EPS VS EstimatesCX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 20 -20 -40 -60

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 9.48, the valuation of CX can be described as reasonable.
Based on the Price/Earnings ratio, CX is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 26.39, CX is valued rather cheaply.
CX is valuated cheaply with a Price/Forward Earnings ratio of 4.19.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CX indicates a rather cheap valuation: CX is cheaper than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.84, CX is valued rather cheaply.
Industry RankSector Rank
PE 9.48
Fwd PE 4.19
CX Price Earnings VS Forward Price EarningsCX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

CX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CX is cheaper than 100.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CX is valued a bit cheaper than 76.92% of the companies in the same industry.
Industry RankSector Rank
P/FCF 31.72
EV/EBITDA 7.91
CX Per share dataCX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

A cheap valuation may be justified as CX's earnings are expected to decrease with -18.89% in the coming years.
PEG (NY)N/A
PEG (5Y)0.12
EPS Next 2Y-30.7%
EPS Next 3Y-18.89%

6

5. Dividend

5.1 Amount

CX has a Yearly Dividend Yield of 22.59%, which is a nice return.
CX's Dividend Yield is rather good when compared to the industry average which is at 2.20. CX pays more dividend than 100.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 1.87, CX pays a better dividend.
Industry RankSector Rank
Dividend Yield 22.59%

5.2 History

CX has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CX Yearly Dividends per shareCX Yearly Dividends per shareYearly Dividends per share 2019 2024 2025 0.05 0.1 0.15 0.2

5.3 Sustainability

CX pays out 9.12% of its income as dividend. This is a sustainable payout ratio.
DP9.12%
EPS Next 2Y-30.7%
EPS Next 3Y-18.89%
CX Yearly Income VS Free CF VS DividendCX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B
CX Dividend Payout.CX Dividend Payout, showing the Payout Ratio.CX Dividend Payout.PayoutRetained Earnings

CEMEX SAB-SPONS ADR PART CER

NYSE:CX (12/19/2025, 8:04:00 PM)

After market: 11.53 -0.13 (-1.11%)

11.66

+0.1 (+0.87%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryConstruction Materials
Earnings (Last)10-28 2025-10-28/bmo
Earnings (Next)02-04 2026-02-04/bmo
Inst Owners25.3%
Inst Owner Change8.93%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap16.92B
Revenue(TTM)15.83B
Net Income(TTM)1.36B
Analysts78.75
Price Target11.85 (1.63%)
Short Float %0.74%
Short Ratio1.19
Dividend
Industry RankSector Rank
Dividend Yield 22.59%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP9.12%
Div Incr Years0
Div Non Decr Years0
Ex-Date12-15 2025-12-15 (0.02238)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-32.04%
Min EPS beat(2)-51.46%
Max EPS beat(2)-12.62%
EPS beat(4)0
Avg EPS beat(4)-38.83%
Min EPS beat(4)-88.35%
Max EPS beat(4)-2.91%
EPS beat(8)1
Avg EPS beat(8)144.98%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.88%
Min Revenue beat(2)-6.15%
Max Revenue beat(2)-1.61%
Revenue beat(4)0
Avg Revenue beat(4)-3.6%
Min Revenue beat(4)-6.15%
Max Revenue beat(4)-1.61%
Revenue beat(8)0
Avg Revenue beat(8)-4.48%
Revenue beat(12)1
Avg Revenue beat(12)-3.51%
Revenue beat(16)2
Avg Revenue beat(16)1.69%
PT rev (1m)15.09%
PT rev (3m)22.99%
EPS NQ rev (1m)0%
EPS NQ rev (3m)100%
EPS NY rev (1m)2.95%
EPS NY rev (3m)16.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.65%
Revenue NY rev (1m)-0.66%
Revenue NY rev (3m)-0.38%
Valuation
Industry RankSector Rank
PE 9.48
Fwd PE 4.19
P/S 1.07
P/FCF 31.72
P/OCF 8.28
P/B 1.24
P/tB 4.21
EV/EBITDA 7.91
EPS(TTM)1.23
EY10.55%
EPS(NY)2.78
Fwd EY23.85%
FCF(TTM)0.37
FCFY3.15%
OCF(TTM)1.41
OCFY12.07%
SpS10.91
BVpS9.38
TBVpS2.77
PEG (NY)N/A
PEG (5Y)0.12
Graham Number16.11
Profitability
Industry RankSector Rank
ROA 4.7%
ROE 10.03%
ROCE 6.73%
ROIC 5.31%
ROICexc 5.67%
ROICexgc 10.4%
OM 9.55%
PM (TTM) 8.62%
GM 32.75%
FCFM 3.37%
ROA(3y)2.44%
ROA(5y)0.96%
ROE(3y)5.81%
ROE(5y)1.39%
ROIC(3y)6.81%
ROIC(5y)6.3%
ROICexc(3y)7.18%
ROICexc(5y)6.61%
ROICexgc(3y)13.44%
ROICexgc(5y)12.5%
ROCE(3y)8.62%
ROCE(5y)7.97%
ROICexgc growth 3Y3.59%
ROICexgc growth 5Y8.98%
ROICexc growth 3Y3.55%
ROICexc growth 5Y10.09%
OM growth 3Y-1.91%
OM growth 5Y2.21%
PM growth 3Y3.44%
PM growth 5Y39.71%
GM growth 3Y1.36%
GM growth 5Y0.48%
F-Score5
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 12.73
Debt/EBITDA 2.16
Cap/Depr 117.98%
Cap/Sales 9.53%
Interest Coverage 250
Cash Conversion 73.17%
Profit Quality 39.1%
Current Ratio 0.91
Quick Ratio 0.67
Altman-Z 1.66
F-Score5
WACC14.53%
ROIC/WACC0.37
Cap/Depr(3y)98.23%
Cap/Depr(5y)87.02%
Cap/Sales(3y)7.21%
Cap/Sales(5y)6.61%
Profit Quality(3y)217.11%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-77.22%
EPS 3Y-35.5%
EPS 5Y76.58%
EPS Q2Q%80%
EPS Next Y-37.74%
EPS Next 2Y-30.7%
EPS Next 3Y-18.89%
EPS Next 5YN/A
Revenue 1Y (TTM)-23.51%
Revenue growth 3Y4.05%
Revenue growth 5Y4.29%
Sales Q2Q%3.81%
Revenue Next Year-5.27%
Revenue Next 2Y-0.21%
Revenue Next 3Y1.3%
Revenue Next 5Y4.14%
EBIT growth 1Y-29.96%
EBIT growth 3Y2.07%
EBIT growth 5Y6.6%
EBIT Next Year60.32%
EBIT Next 3Y22.39%
EBIT Next 5YN/A
FCF growth 1Y-51.1%
FCF growth 3Y-11.58%
FCF growth 5Y-3.16%
OCF growth 1Y-17.47%
OCF growth 3Y0.91%
OCF growth 5Y6.96%

CEMEX SAB-SPONS ADR PART CER / CX FAQ

What is the ChartMill fundamental rating of CEMEX SAB-SPONS ADR PART CER (CX) stock?

ChartMill assigns a fundamental rating of 4 / 10 to CX.


What is the valuation status of CEMEX SAB-SPONS ADR PART CER (CX) stock?

ChartMill assigns a valuation rating of 6 / 10 to CEMEX SAB-SPONS ADR PART CER (CX). This can be considered as Fairly Valued.


What is the profitability of CX stock?

CEMEX SAB-SPONS ADR PART CER (CX) has a profitability rating of 4 / 10.


What is the expected EPS growth for CEMEX SAB-SPONS ADR PART CER (CX) stock?

The Earnings per Share (EPS) of CEMEX SAB-SPONS ADR PART CER (CX) is expected to decline by -37.74% in the next year.


Can you provide the dividend sustainability for CX stock?

The dividend rating of CEMEX SAB-SPONS ADR PART CER (CX) is 6 / 10 and the dividend payout ratio is 9.12%.